IVVD (STOCKS)
Invivyd, Inc. Common Stock
$0.969900
+0.038700 (+4.16%)
Prev close: $0.931200
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- William E. Duke
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $281.54M
- Employees
- 100
- P/E (TTM)
- -2.72
- P/B (TTM)
- 1.35
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $55.87M |
| Benefits Costs and Expenses | $134.42M |
| Costs And Expenses | $137.64M |
| Nonoperating Income/Loss | $4.17M |
| Operating Expenses | $137.64M |
| Selling, General, and Administrative Expenses | $75.30M |
| Research and Development | $58.40M |
| Other Operating Expenses | $3.95M |
| Operating Income/Loss | -$81.77M |
| Income/Loss From Continuing Operations After Tax | -$77.60M |
| Income/Loss From Continuing Operations Before Tax | -$78.15M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$77.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$77.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$77.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.31 |
| Diluted Earnings Per Share | -$0.31 |
| Basic Average Shares | 635,194,975 |
| Diluted Average Shares | 635,194,975 |
| Assets | $241.74M |
| Current Assets | $204.92M |
| Noncurrent Assets | $36.83M |
| Fixed Assets | $1.69M |
| Other Non-current Assets | $35.13M |
| Liabilities | $38.69M |
| Current Liabilities | $31.66M |
| Accounts Payable | $2.02M |
| Other Current Liabilities | $29.64M |
| Noncurrent Liabilities | $7.03M |
| Equity | $203.05M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $203.05M |
| Liabilities And Equity | $241.74M |
| Net Cash Flow From Operating Activities | -$78.72M |
| Net Cash Flow From Operating Activities, Continuing | -$78.72M |
| Net Cash Flow From Investing Activities | -$737.00K |
| Net Cash Flow From Investing Activities, Continuing | -$737.00K |
| Net Cash Flow From Financing Activities | $215.52M |
| Net Cash Flow From Financing Activities, Continuing | $215.52M |
| Net Cash Flow | $136.07M |
| Net Cash Flow, Continuing | $136.07M |
| Comprehensive Income/Loss | -$77.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$77.62M |
| Other Comprehensive Income/Loss | -$10.47M |